Lucina Biotherapeutics Revenue

Biotechnology Research • 2161 Delaware Ave, E, United States • 1-10 Employees

Lucina Biotherapeutics revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at Lucina Biotherapeutics

Marty Emanuele

Co-Founder & Executive Chairman

Company overview

Headquarters	2161 Delaware Ave, E, Santa Cruz, California 95060, US
Website	lucina.bio
NAICS	541714
Founded	2024
Employees	1-10
Socials

Lucina Biotherapeutics Email Formats

Lucina Biotherapeutics uses 1 email format. The most common is {first name} (e.g., john@lucina.bio), used 100% of the time.

Format	Example	Percentage
{first name}	john@lucina.bio	100%

About Lucina Biotherapeutics

Lucina Biotherapeutics is pioneering a new class of therapeutics designed to restore essential molecules lost with age. Leveraging advanced synthetic biology, we develop lipid-based interventions that address the molecular drivers of age-related diseases. Our lead program targets dry age-related macular degeneration (AMD), a condition driven by the decline of retina-specific lipids. By replenishing these vital lipids, Lucina aims to preserve vision, enhance cellular resilience, and extend human healthspan and longevity.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Lucina Biotherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Lucina Biotherapeutics has never raised funding before.

Frequently asked questions

Lucina Biotherapeutics is located in 2161 Delaware Ave, E, US.

Lucina Biotherapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Lucina Biotherapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Lucina Biotherapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Lucina Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Lucina Biotherapeutics

Marty Emanuele

Co-Founder & Executive Chairman

4.8

40,000 users